L-644

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameL-644
Drug Alias NameHIV gp41 fusion inhibitors (Merck/IPM)HIV gp41 fusion inhibitors (Merck)L-644L-644
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInternational Partnership For Microbicides IncMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A